HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Assessment of haemoglobin and serum markers of iron deficiency in people with cardiovascular disease.

AbstractBACKGROUND:
The prevalence of anaemia and iron deficiency and their prognostic association with cardiovascular disease have rarely been explored at population level.
METHODS:
National Health Service records of the Greater Glasgow region for patients aged ≥50 years with a broad range of cardiovascular diagnoses were obtained. During 2013/14, prevalent disease was identified and results of investigations collated. Anaemia was defined as haemoglobin <13 g/dL for men or <12 g/dL for women. Incident heart failure, cancer and death between 2015 and 2018 were identified.
RESULTS:
The 2013/14 dataset comprised 197 152 patients, including 14 335 (7%) with heart failure. Most (78%) patients had haemoglobin measured, especially those with heart failure (90%). Of those tested, anaemia was common both in patients without (29%) and with heart failure (prevalent cases in 2013/14: 46%; incident cases during 2013/14: 57%). Ferritin was usually measured only when haemoglobin was markedly depressed; transferrin saturation (TSAT) even less often. Incidence rates for heart failure and cancer during 2015-18 were inversely related to nadir haemoglobin in 2013/14. A haemoglobin of 13-15 g/dL for women and 14-16 g/dL for men was associated with the lowest mortality. Low ferritin was associated with a better prognosis and low TSAT with a worse prognosis.
CONCLUSION:
In patients with a broad range of cardiovascular disorders, haemoglobin is often measured but, unless anaemia is severe, markers of iron deficiency are usually not. Low haemoglobin and TSAT, but not low ferritin, are associated with a worse prognosis. The nadir of risk occurs at haemoglobin 1-3 g/dL above the WHO definition of anaemia.
AuthorsFraser J Graham, Jocelyn M Friday, Pierpaolo Pellicori, Nicola Greenlaw, John Gf Cleland
JournalHeart (British Cardiac Society) (Heart) Vol. 109 Issue 17 Pg. 1294-1301 (08 11 2023) ISSN: 1468-201X [Electronic] England
PMID37130747 (Publication Type: Journal Article)
Copyright© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ.
Chemical References
  • Hemoglobins
  • Ferritins
  • Biomarkers
Topics
  • Male
  • Humans
  • Female
  • Anemia, Iron-Deficiency (diagnosis, epidemiology)
  • Cardiovascular Diseases (diagnosis, epidemiology, complications)
  • State Medicine
  • Iron Deficiencies
  • Hemoglobins
  • Heart Failure (complications, diagnosis, epidemiology)
  • Anemia (diagnosis, epidemiology, complications)
  • Ferritins
  • Biomarkers

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: